Fibrobiologics Inc (FBLG)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.96-1.22%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · FBLG
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 65 industry peers · Company calendar date is not available
FBLG — private placement
Dated 2026-10-08
Entry into a Material Definitive Agreement. On October 7, 2026, FibroBiologics, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Peak One Opportunity Fund, L.P. (“Peak One”), pursuant to which the Company agreed to issue to Peak One, in a private placement offering (the “Offering”) upon the satisfaction of certain conditions specified in the SPA, a convertible debenture in the principal amount of $1,200,000 (the “Debenture”) and 125,000 restricted shares (the…
Why it matters: The company has a Nasdaq bid-price issue. A clear compliance plan or regained compliance would address this listing risk.
Worry ifA filing says Nasdaq has started delisting steps. Or the company misses its stated deadline to regain compliance.
Less concerning ifA filing confirms the company met Nasdaq's bid-price rules again.
Why it matters: The October financing adds cash, but a convertible debenture can add debt and shares. The final terms show the funding cost.
Worry ifA filing confirms the debenture was issued. It reports terms that require repayment or allow conversion into shares.
Less concerning ifThe deal does not close, or a filing shows the debenture was repaid without conversion or added share issuance.
Why it matters: Losses have stayed high, and the company names cash burn as a priority. A lower loss would show spending pressure easing.
Worry ifThe next quarterly filing reports operating loss above $4.0 million, worse than 2026-Q2.
Less concerning ifThe next quarterly filing shows an operating loss under $4.0 million, less than in 2026-Q2.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$375 on $10,000 · ±3.7% | How much price usually moves either way. |
| Bad day | $1,029 loss on $10,000 · 10.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,279 loss on $10,000 · 92.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.